Add to Calendar 1/16/2019 4:00:00 PM 1/16/2019 6:00:00 PM 2019 JP Morgan Recap: Insider's View The annual JP Morgan Healthcare Conference in San Francisco is one of the largest and most informative healthcare investment symposiums in the industry. It brings together global industry leaders, emerging fast-growth companies, innovative technology creators and members of the investment community. Each year hundreds of companies, both public and private, deliver presentations to over 4,000 investors. In addition, thousands in biotech descend upon San Francisco to network, attend meetings and gain an inside view even if they can’t secure an official conference invite. With the Trump administration geared up to make some changes, what can we expect in 2019 in regard to drug pricing, the regulatory environment and capital markets. If you can’t make it to the conference, or if your role does not require you to attend the JP Morgan conference, join us for a recap of it and hear from a select group of Conference insiders. MassBio, 300 Technology Square 8th Fl, Cambridge, MA 02139
President and CEO, Morphic Therapeutic Inc.
Praveen Tipirneni, MD, MBA is Chief Executive Officer of Morphic Therapeutic Inc. Previously, he was Senior Vice President of Corporate Development and Global Strategy at Cubist Pharmaceuticals, a position in which he served from 2002 until the company’s acquisition by Merck in 2015. In his time at Cubist, he was a member of the clinical group working on the Cubicin NDA (skin and skin structure infections) and sNDA (Staph. Bacteremia and Endocarditis) teams. He was head of business development since January 2006. Prior to joining Cubist, Dr. Tipirneni worked at Sun Microsystems in corporate strategy, Covad Communications in Corporate Strategy, and Deltagen in business development. He also served time as a 1st Lieutenant in the U.S. Army. Dr. Tipirneni received a bachelor’s degree from MIT in mechanical engineering and an M. D. from McGill University. After completing his post-graduate residency in Internal Medicine at University of Illinois, Chicago, he received his MBA from the University of Pennsylvania’s Wharton School of Business in healthcare finance.